Cereno Scientific reports insider share purchase
Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that an insider share purchase has been completed. Sverker Jern, a co-founder of Cereno and board member, purchased a total of 366,828 shares on July 24, 2023, to a value of 0.65-0.659 per share on the Nasdaq First North Growth Market marketplace.The share purchase was completed over four transactions: 99,590 shares to a value of 0.659 per share, 125,238 shares to a value of 0.65 per share, 71,000 shares to a value of 0.652 per share, and 71,